(Q46034432)

18 December 2017

title

Statin effects on LDL and HDL cholesterol in South Asian and white populations. (English)

1 reference

18 December 2017

1

Milan Gupta

0 references

Hwee Teoh

object named as

Hwee Teoh

3

0 references

author name string

Manoela F B Braga

2

1 reference

18 December 2017

Michelle Tsigoulis

4

1 reference

18 December 2017

Subodh Verma

5

1 reference

18 December 2017

publication date

27 April 2009

1 reference

18 December 2017

The Journal of Clinical Pharmacology

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 December 2017

volume

49

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

831-837

1 reference

18 December 2017

South Asians and cardiovascular risk: what clinicians should know

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

A review and assessment of potential sources of ethnic differences in drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Safety and efficacy of statins in Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009334376

21 January 2018

Identifiers

DOI

10.1177/0091270009334376

1 reference

18 December 2017

PubMed ID

19398601

1 reference

18 December 2017